Can baricitinib and hydroxychloroquine be taken at the same time?

Baricitinib tablets are a selective immunosuppressive drug, mainly used to treat moderately to severely active rheumatoid arthritis that is ineffective or intolerant to one or more disease-modifying anti-rheumatic drugs (DMARD). However, it comes with some important safety warnings, including possible risks of serious infection, malignancy, and thrombosis.

Hydroxychloroquine is an antimalarial drug that also has anti-inflammatory, immune-regulating, and anti-infective effects. It is suitable for the treatment of malaria, allergies, and autoimmune diseases. Retinal toxicity of hydroxychloroquine is one of its main adverse reactions, and regular eye examinations are required to ensure the safety of the drug.

When considering whether two drugs can be used together, it is critical to evaluate whether there are adverse drug interactions between them and whether these interactions may increase the risk of adverse effects. Based on current information, there are no clear contraindications or known serious interactions between baricitinib and hydroxychloroquine. However, this does not mean that they can be used simultaneously without causing any problems.

Both drugs have immunomodulatory and anti-inflammatory effects, so concurrent use may increase the degree of immunosuppression and thus the risk of infection. Additionally, baricitinib itself has been associated with an increased risk of serious infections, so concomitant use with hydroxychloroquine may further exacerbate this risk.

There is some overlap in the pharmacological effects of baricitinib and hydroxychloroquine, both involving immunomodulation and anti-inflammatory effects. Using these two drugs together may increase the risk of immunosuppression and infection. The patient's specific medical condition, immune status, and potential drug interactions should be fully considered before deciding whether to use these two drugs together. It is recommended to use these two drugs under the guidance of a doctor and to closely monitor patients for adverse reactions and signs of infection.